Michael S. Aberman, SVP Strategy Investor Relation at REGENERON PHARMACEUTICALS INC (REGN), sold 7,500 shares at $405.56 ($3.0M) on 2015-02-17, disclosed to the SEC on 2015-02-18.
Scheduled sale ($3.0M) by SVP Strategy Investor Relation under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $402.05 | 447 | $180K | 5.9% |
| 2 | $402.05 | 3,361 | $1.4M | 44.7% |
| 3 | $401.54 | 100 | $40K | 1.3% |
| 4 | $402.51 | 300 | $121K | 4.0% |
| 5 | $403.72 | 600 | $242K | 8.0% |
| 6 | $404.55 | 1,692 |
| $684K |
| 22.6% |
| 7 | $405.56 | 900 | $365K | 12.1% |
| 8 | $406.24 | 100 | $41K | 1.3% |
| Total | $403.24 avg | 7,500 | $3.0M | 100% |
| Filing → |
| REGN | SELL | 2015-03-19 | $1.6M | — | Filing → |
| REGN | SELL | 2015-02-25 | $1.4M | — | Filing → |
| REGN | SELL | 2014-08-19 | $1.3M | — | Filing → |